skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 77,996  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Material Type:
Article 		Add to My Research

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

New England Journal of Medicine, 2022-06, Vol.386 (22), p.2084-2096 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2201300 ;PMID: 35507508

Digital Resources/Online E-Resources

Citations Cited by
2
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR super(+) breast cancer: the ProBONE II study
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR super(+) breast cancer: the ProBONE II study
Material Type:
Article 		Add to My Research

Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR super(+) breast cancer: the ProBONE II study

Osteoporosis international, 2014-04, Vol.25 (4), p.1369-1378 [Peer Reviewed Journal]

ISSN: 0937-941X ;EISSN: 1433-2965 ;DOI: 10.1007/s00198-013-2615-z

Full text available

Citations Cited by
3
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by super(18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by super(18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity
Material Type:
Article 		Add to My Research

Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by super(18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity

European journal of nuclear medicine and molecular imaging, 2014-03, Vol.41 (3), p.452-461 [Peer Reviewed Journal]

ISSN: 1619-7070 ;EISSN: 1619-7089 ;DOI: 10.1007/s00259-013-2571-z

Full text available

Citations Cited by
4
The mechanism of action of MF59 – An innately attractive adjuvant formulation
The mechanism of action of MF59 – An innately attractive adjuvant formulation
Material Type:
Article 		Add to My Research

The mechanism of action of MF59 – An innately attractive adjuvant formulation

Vaccine, 2012-06, Vol.30 (29), p.4341-4348 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 19, 2012 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.09.061 ;PMID: 22682289

Full text available

Citations Cited by
5
HYPOFRACTIONATION WITH TOMOTHERAPY FOR PROSTATE CANCER: TOXICITIES AND OUTCOMES IN 82 PATIENTS TREATED IN MODENA
HYPOFRACTIONATION WITH TOMOTHERAPY FOR PROSTATE CANCER: TOXICITIES AND OUTCOMES IN 82 PATIENTS TREATED IN MODENA
Material Type:
Article 		Add to My Research

HYPOFRACTIONATION WITH TOMOTHERAPY FOR PROSTATE CANCER: TOXICITIES AND OUTCOMES IN 82 PATIENTS TREATED IN MODENA

Anticancer research, 2013-05, Vol.33 (5), p.2262-2263 [Peer Reviewed Journal]

ISSN: 0250-7005 ;EISSN: 1791-7530

Full text available

Citations Cited by
6
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Material Type:
Article 		Add to My Research

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

The New England journal of medicine, 2018-05, Vol.378 (19), p.1789-1801 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1802357 ;PMID: 29658430

Full text available

Citations Cited by
7
TLR-based immune adjuvants
TLR-based immune adjuvants
Material Type:
Article 		Add to My Research

TLR-based immune adjuvants

Vaccine, 2011-04, Vol.29 (17), p.3341-3355 [Peer Reviewed Journal]

2010 ;Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 12, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.08.002 ;PMID: 20713100

Full text available

Citations Cited by
8
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
Material Type:
Article 		Add to My Research

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1352-1361 [Peer Reviewed Journal]

The Author 2017 ;The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. 2017 ;The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jix481 ;PMID: 29029224

Full text available

Citations Cited by
9
self-assembling peptide acting as an immune adjuvant
self-assembling peptide acting as an immune adjuvant
Material Type:
Article 		Add to My Research

self-assembling peptide acting as an immune adjuvant

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (2), p.622-627 [Peer Reviewed Journal]

Copyright National Academy of Sciences Jan 12, 2010 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0912124107 ;PMID: 20080728

Full text available

Citations Cited by
10
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease
A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease
Material Type:
Article 		Add to My Research

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

International journal of molecular sciences, 2022-02, Vol.23 (3), p.1850 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms23031850 ;PMID: 35163772

Full text available

Citations Cited by
11
Alum adjuvant: some of the tricks of the oldest adjuvant
Alum adjuvant: some of the tricks of the oldest adjuvant
Material Type:
Article 		Add to My Research

Alum adjuvant: some of the tricks of the oldest adjuvant

Journal of medical microbiology, 2012-07, Vol.61 (Pt 7), p.927-934 [Peer Reviewed Journal]

ISSN: 0022-2615 ;EISSN: 1473-5644 ;DOI: 10.1099/jmm.0.038943-0 ;PMID: 22174375

Full text available

Citations Cited by
12
A novel mitogen fusion protein against CD40 super(+) cells with potent vaccine adjuvant properties
A novel mitogen fusion protein against CD40 super(+) cells with potent vaccine adjuvant properties
Material Type:
Article 		Add to My Research

A novel mitogen fusion protein against CD40 super(+) cells with potent vaccine adjuvant properties

Vaccine, 2010-05, Vol.28 (21), p.3688-3695 [Peer Reviewed Journal]

ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.03.014

Full text available

Citations Cited by
13
Prothymosin [alpha] and a prothymosin [alpha]-derived peptide enhance T sub(H)1-type immune responses against defined HER-2/neu epitopes
Prothymosin [alpha] and a prothymosin [alpha]-derived peptide enhance T sub(H)1-type immune responses against defined HER-2/neu epitopes
Material Type:
Article 		Add to My Research

Prothymosin [alpha] and a prothymosin [alpha]-derived peptide enhance T sub(H)1-type immune responses against defined HER-2/neu epitopes

BMC immunology, 2013-01, Vol.14 (1), p.43-43 [Peer Reviewed Journal]

ISSN: 1471-2172 ;EISSN: 1471-2172 ;DOI: 10.1186/1471-2172-14-43

Full text available

Citations Cited by
14
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Material Type:
Article 		Add to My Research

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709030 ;PMID: 28891423

Full text available

Citations Cited by
15
Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants
Material Type:
Article 		Add to My Research

Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants

Frontiers in immunology, 2022-05, Vol.13, p.865507-865507 [Peer Reviewed Journal]

Copyright © 2022 Fuentes, Aguinagalde, Pifferi, Plata, Sacristán, Castellana, Anguita and Fernández-Tejada. ;Copyright © 2022 Fuentes, Aguinagalde, Pifferi, Plata, Sacristán, Castellana, Anguita and Fernández-Tejada 2022 Fuentes, Aguinagalde, Pifferi, Plata, Sacristán, Castellana, Anguita and Fernández-Tejada ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.865507 ;PMID: 35603193

Full text available

Citations Cited by
16
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Material Type:
Article 		Add to My Research

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

The New England journal of medicine, 2023-02, Vol.388 (7), p.595-608 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209604 ;PMID: 36791160

Full text available

Citations Cited by
17
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
Material Type:
Article 		Add to My Research

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1813-1823 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1708539 ;PMID: 28891408

Full text available

Citations Cited by
18
The use of 4-Hexylresorcinol as antibiotic adjuvant
The use of 4-Hexylresorcinol as antibiotic adjuvant
Material Type:
Article 		Add to My Research

The use of 4-Hexylresorcinol as antibiotic adjuvant

PloS one, 2020-09, Vol.15 (9), p.e0239147 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Nikolaev et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Nikolaev et al 2020 Nikolaev et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0239147 ;PMID: 32960928

Full text available

Citations Cited by
19
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients
Material Type:
Article 		Add to My Research

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients

Journal for immunotherapy of cancer, 2019-06, Vol.7 (1), p.163-13, Article 163 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1186/s40425-019-0625-x ;PMID: 31248461

Full text available

Citations Cited by
20
CpG DNA as a vaccine adjuvant
CpG DNA as a vaccine adjuvant
Material Type:
Article 		Add to My Research

CpG DNA as a vaccine adjuvant

Expert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]

Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647

Full text available

Citations Cited by

Results 1 - 20 of 77,996  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (71,179)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (199)
  2. 1964 To 1978  (2,447)
  3. 1979 To 1993  (4,938)
  4. 1994 To 2009  (28,538)
  5. After 2009  (41,939)
  6. More options open sub menu

Subject 

  1. Science & Technology  (63,089)
  2. Life Sciences & Biomedicine  (60,612)
  3. Humans  (48,318)
  4. Female  (35,704)
  5. Male  (23,498)
  6. Oncology  (21,983)
  7. Animals  (21,487)
  8. Middle Aged  (21,099)
  9. Chemotherapy, Adjuvant  (18,458)
  10. Adult  (17,141)
  11. Aged  (17,004)
  12. Biological And Medical Sciences  (16,542)
  13. Immunology  (13,576)
  14. Medical Sciences  (13,072)
  15. Treatment Outcome  (12,283)
  16. Mice  (12,074)
  17. Surgery  (11,982)
  18. Chemotherapy  (11,224)
  19. Tumors  (9,519)
  20. Cancer  (9,485)
  21. More options open sub menu

Language 

  1. English  (75,334)
  2. Japanese  (9,728)
  3. German  (1,168)
  4. French  (620)
  5. Portuguese  (443)
  6. Spanish  (316)
  7. Russian  (149)
  8. Korean  (125)
  9. Chinese  (113)
  10. Polish  (83)
  11. Norwegian  (59)
  12. Italian  (45)
  13. Swedish  (39)
  14. Hungarian  (33)
  15. Persian  (29)
  16. Turkish  (24)
  17. Czech  (22)
  18. Croatian  (21)
  19. Serbian  (10)
  20. Romanian  (9)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait